FDA-Drug2019-03-20Class III
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
Lannett Company Inc.
Hazard
Failed Dissolution Specifications
Sold states
Nationwide, including Puerto Rico.
Affected count
14,448 bottles
Manufactured in
1101 C Ave W, N/A, Seymour, IN, United States
Products
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0996-2019Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief